WebInformatii prospect Multaq. Prezentare. Multaq (dronedarona) 400 mg tablete. Indicatii. Multaq este un medicament anti-aritmic indicat pentru reducerea riscului de spitalizare … WebAmiodarone pulmonary toxicity can present in various ways: pneumonia interstitial disease, respiratory distress or solitary pulmonary masses. Clinical scenarios are variable, the most common symptoms being dyspnea and dry cough, but symptoms can also include fever, weight loss, hemoptysis and chest pain aggravated by breathing movements.
Savings & Support For Your Patients MULTAQ® (dronedarone) …
WebRisk of interstitial lung disease in patients treated for atrial fibrillation with dronedarone versus other antiarrhythmics ILD risk among AF patients initiated on dronedarone therapy was comparable to or lower than that of amiodarone initiators, and similar to that of new sotalol or flecainide users. WebThe FDA warns that cases of interstitial lung disease including pneumonitis and pulmonary fibrosis have been reported with the use of dronedarone [15]. According to the FDA, patients with the onset of dyspnea or nonproductive cough while on dronedarone should be evaluated for pulmonary toxicity [15]. The purpose of this case report is to ... sets theory notes
Multaq Warnings Include Lung Disease, Pulmonary Toxicity
WebPulmonary Toxicity: Cases of interstitial lung disease including pneumonitis and pulmonary fibrosis have been reported in patients treated with MULTAQ in the post-marketing setting [see Adverse Reactions (6.2)]. Onset of dyspnea or non-productive cough may be related to pulmonary toxicity and patients should be carefully evaluated clinically. Web12 sept. 2012 · If pulmonary toxicity is confirmed, MULTAQ should be discontinued. Under “What are the possible side effects of MULTAQ,” the following information has been … Web9 oct. 2016 · One of the more serious adverse effects includes amiodarone pulmonary toxicity (APT). Several pulmonary diseases can manifest including interstitial pneumonitis, organizing pneumonia, acute respiratory distress syndrome, diffuse alveolar hemorrhage, pulmonary nodules or masses, and pleural effusion. sets the metaclass of class a to b